PILL 3x Leverage Medical/ Pharma ETF for swing LONGAMEX:PILL
On the 4H Chart, current market price is sitting on the support
of order blocks and the EMA200, while in an uptend from
a double bottom in the sprint. It is moving into the high volume
area of the voluxme profile. For the swing trade, the stop loss is
$0.10 below the EMA200 while the targets are marked
based on a combination of the horizontal resistances of
prior swing pivots along with sell order blocks and
the structure of the volume profile. Accordingly, this
trade risks $0.60 for about $ 4 to $ 5 of upside making for
an excellent swing setup especially since healthcare, medical
and pharmacueticals are known to be recession resilient and
ETFs are inherently diversified making leveraging a risk probably
worth taking.
CURE
STAA medical suppy small cap catching up from Covid LONGSTAA is a medical company specialized in implantable lenses. Many of those needing
lens replacements for cataracts put things off during the COVID era and eye surgeons are now
catching up on backed up patient loads. Medical insurance companies are burdened with
patients catching up from the covid delays for elective surgeries. The surgeons and medical
supply companies on the other hand are experiencing growth.
CURECOIN CURE USD : MULTI YEAR BULL FLAG BREAKOUT TARGET $8.60CURECOIN CURE USD is looking primed with a multi year consolidation correction which has formed a bull flag. Cure is now on some major support and I believe that we will see the next breakout sooner than later. If we break below support then one more test of the bottom of the channel/bullflag before heading up. I dont think that is what will happen though. I have done analysis on many other coins and projects similar to Cure that are sleeper picks and possible massive reward to risk ratio. This is not financial advice this is just my opinion and what I am doing. If you appreciate this content then please leave a like and follow me for more updates and analysis. Thank you and good luck.
IOVA - IOVANCE FINISHED FUELING UP AND ABOUT TO TURN ON ENGINEIovance Biotherapeutics aims to improve patient care by making T cell-based immunotherapies broadly accessible for the treatment of patients with solid tumors and blood cancers. Tumor infiltrating lymphocyte (TIL) therapy uses a patient's own immune cells to attack cancer. TIL cells are extracted from a patient's own tumor tissue, expanded through a proprietary process, and infused back into the patient. Upon infusion, TIL reach tumor tissue, where they attack cancer cells. The company has completed dosing in the pivotal study in patients with metastatic melanoma and cervical cancer. In addition, the company's TIL therapy is being investigated for the treatment of patients with locally advanced, recurrent or metastatic cancers including head and neck and non-small cell lung cancer. A clinical study to investigate Iovance T cell therapy for blood cancers called peripheral blood lymphocyte (PBL) therapy is open to enrollment.
What an amazing opportunity. RISK 5% REWARD 22% 4.44 RISK TO REWARD RATIO
Enough cash on hand ~$720M cash (9/30/20) to last 3 years of R&D
2021 - Year to get some FDA News - HUGE POTENTIAL MARKET FOR CANCER TREATMENT
Research/ Study showing promise.
Developing Iovance manufacturing facility plans for commercialization 75 Million$ Investment scheduled for completion this year.
CUREBTC analysisMoon, buy2 and green robo signal. This chart is about to take off, enjoy your profits. Risk/reward ratio is greater than 2 aswell.
For sell decision, sell2, hell, red robo signals or below support after confirming (1D open close)
CureCoin Big Numbers (1900% or 4100% | Low Cap. = Big Potential)CureCoin (CUREBTC) is starting to move after 3.5 years of bear action... The same can happen in reverse, imagine 3-5 years of bullish action, the big numbers on the title/screen are completely possible.
When we look at the current price for CureCoin compared to the ATH, there is 1900%+ of potential growth.
If we calculate a new ATH based on Fib. proportions, we are looking at 4,100%+.
Cryptocurrency is really crazy (wild, fun, highly profitable and risky) and crazy sometimes means beautiful in this world.
Thanks a lot for your continued support.
Namaste.
CURE/BTC strategyCURE looks good, it can go up next hours...
8146 is an important resistance if it breaks it, it goes to the moon!
Buy CIRE for 8100-8300
Sell after +10%-25%
CURE/BTC AnalysisCURE looks good, it can go up next hours...
8146 is an important resistance if it breaks it, it goes to the moon!
Buy CIRE for 8100-8300
Sell after +10%-25%
HOW I MAKE FROM 8-30% ON CURE COIN CONSOLIDATION.Trade recommendation:
If you intend to Wait for a bullish trade or move upwards Fib extension levels are good points to look at.As the relation of the candles looks hood and so does the MACD.
To catch the pumps
CUREBTC Can be said to have a lot experiences with pumps and dumps so we might as well use this to our advantage.
1.Entry levels set at or bellow support But should not affect stop loss at about Floor.
2.Conditional Orders(partial or full) placed to open at Target 1 with an alert above Target 1.
3.Set alert for point for if candle gets to level to move Sell order.
4.Do the same as (2) for when the candle goes above 2 for 3
5.Set alerts for stop loss positions.
6.3:1 Reward to loss but Regulate to fit levels you choose to use as stop loss for Target 1 is 0.00000161 and for 2 is at 0.00000240.
7. Use SMS alerts or Blockfolio for best alerts.
How this works if the candle activates the buy order you don't get sold out and and you can wait for a break above target 2 to move sell order to target 2 and so on. When prices start to move down sell levels will be filled.
P.S This is a very risky strategy so trade it carefully and watch stop loss well and try some sizing here.
Thank you and a Good Day.
CUREBTC - research coin pump(s)I think we'll see a $CURE pump durring the next altcoin season.
Usualy it pumps alongside other research coins like $FLDC, $GRC. And I have a good feeling about them in 2017.